These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1406237)

  • 81. Molecular Epidemiology, prenatal exposure and prevention of cancer.
    Perera F
    Environ Health; 2011 Apr; 10 Suppl 1(Suppl 1):S5. PubMed ID: 21489215
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In favor of controlling proven, but not probable, causes of cancer.
    Erren TC; Gross JV; Morfeld P
    Environ Health Perspect; 2011 Nov; 119(11):A469; author reply A469-70. PubMed ID: 22224196
    [No Abstract]   [Full Text] [Related]  

  • 83. "The Apocalyptics".
    Karstadt M
    Environ Res; 1985 Apr; 36(2):490-500. PubMed ID: 3979366
    [No Abstract]   [Full Text] [Related]  

  • 84. Applicability of cancer risk assessment techniques to other toxic effects.
    Gaylor DW
    Toxicol Ind Health; 1988 Dec; 4(4):453-9. PubMed ID: 3188043
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of repair processes on dose-response models.
    Downs TD; Frankowski RF
    Drug Metab Rev; 1982; 13(5):839-52. PubMed ID: 6754311
    [No Abstract]   [Full Text] [Related]  

  • 86. Response to a letter from Philip Kuehl.
    Hardy CJ
    Inhal Toxicol; 2009 Dec; 21(14):1153. PubMed ID: 19827987
    [No Abstract]   [Full Text] [Related]  

  • 87. The future of population monitoring in cancer research.
    Cardis E; Jones S; Kleihues P
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):527-8. PubMed ID: 8781376
    [No Abstract]   [Full Text] [Related]  

  • 88. Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm.
    Mohrenweiser HW
    Toxicol Pathol; 2004; 32 Suppl 1():136-45. PubMed ID: 15209414
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mathematical planning and evaluation of experiments.
    Misfeld J; Timm J
    IARC Sci Publ (1971); 1977; (16):11-28. PubMed ID: 873531
    [No Abstract]   [Full Text] [Related]  

  • 90. Observable tumours, risk assessment and experimental design.
    Carlborg FW
    Food Chem Toxicol; 1984 Jan; 22(1):69-73. PubMed ID: 6537940
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human risk factors to naturally occurring carcinogens: thresholds, inhibitors and inducers.
    Waddell WJ
    J Toxicol Sci; 1993 May; 18(2):73-82. PubMed ID: 8331695
    [No Abstract]   [Full Text] [Related]  

  • 92. The carcinogenic effect of exposure to low doses of carcinogens.
    Tubiana M
    Br J Ind Med; 1992 Sep; 49(9):601-5. PubMed ID: 1390264
    [No Abstract]   [Full Text] [Related]  

  • 93. Biological monitoring in occupational and environmental toxicology.
    Mutti A
    Toxicol Lett; 1999 Sep; 108(2-3):77-89. PubMed ID: 10511249
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Carcinogenicity testing and safety assessment.
    Squire RA
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 2):S326-34. PubMed ID: 6745551
    [No Abstract]   [Full Text] [Related]  

  • 95. No dose-no poison.
    Froom P
    Environ Health Prev Med; 2012 Jul; 17(4):346. PubMed ID: 22307820
    [No Abstract]   [Full Text] [Related]  

  • 96. The identification, assessment and control of environmental carcinogens in New South Wales and Australia.
    Billett J
    N S W Public Health Bull; 2002; 13(9-10):205-8. PubMed ID: 12555111
    [No Abstract]   [Full Text] [Related]  

  • 97. Age-specific mortality rate analysis: a new paradigm for risk assessment.
    Neafsey PJ
    Drug Metab Rev; 1989-1990; 21(3):471-85. PubMed ID: 2701172
    [No Abstract]   [Full Text] [Related]  

  • 98. A balanced approach to risk assessment.
    Hoel DG
    Toxicol Ind Health; 1991; 7(5-6):305-11. PubMed ID: 1780871
    [No Abstract]   [Full Text] [Related]  

  • 99. Basic problems in interaction assessment.
    Greenland S
    Environ Health Perspect; 1993 Dec; 101 Suppl 4(Suppl 4):59-66. PubMed ID: 8206043
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Procedures for calculating cessation lag.
    Chen CW; Gibb H
    Regul Toxicol Pharmacol; 2003 Oct; 38(2):157-65. PubMed ID: 14550757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.